Skip to main content

Atalan

Category: AI in Healthcare

A Clinical Retention Intelligence (CRI) platform that leverages machine learning to predict and prevent clinician burnout and turnover by analyzing EHR and HRIS data. Atalan was founded in 2021. The company is led by Tiffany Chan. Based in Philadelphia, USA. Team size: 11-50. Total funding raised: $4.4M. Latest round: Seed. Key investors include OCA Ventures, Excelerate Health Ventures, BioAdvance, Ben Franklin Technology Partners, Early Light Ventures.

Founded
2021
Headquarters
Philadelphia, USA
Team size
11-50
Total funding
$4.4M

Value proposition

Reduces the high financial and operational costs of clinician turnover by predicting resignations up to 12 months in advance and providing data-driven, proactive interventions.

Products and solutions

CRI (Clinical Retention Intelligence) Platform, Atalan PX (Patient Experience Intelligence Module), Predictive Workforce Analytics Dashboard, Early Warning & Monitoring System

Unique value

Pioneered the 'Clinical Retention Intelligence' category, moving beyond traditional reactive surveys to deep integration of clinical workflow data (EHR) and labor economics.

Target customer

Large healthcare systems, hospital administrators, Chief Wellness Officers, and HR leadership.

Industries served

Healthcare, HealthTech, Human Resources / Workforce Management, Data Analytics

Technology advantage

Proprietary machine learning models analyze over 100 factors—including 'silent' burnout signals within Electronic Health Records—to identify at-risk clinicians before they manifest intent to leave.

How they differentiate

Atalan differentiates by moving beyond reactive, survey-based tools. It uses 'Clinical Retention Intelligence' (CRI) to analyze 'silent signals' within EHR (Electronic Health Record) and HRIS data—such as time spent on documentation and clinical workflow patterns—to predict burnout up to 12 months in advance.

Main competitors

Laudio, Qualtrics (Healthcare Employee Experience), Relias

Key partnerships

Bon Secours Mercy Health (BSMH), Accrete Health Partners (Strategic co-development partner), BioAdvance, Ben Franklin Technology Partners, Excelerate Health Ventures

Notable customers

Bon Secours Mercy Health (BSMH), Accrete Health Partners

Major milestones

Closed $2.5M Seed funding round in October 2023, Established strategic partnership with Bon Secours Mercy Health to launch Atalan PX, Pioneered the 'Clinical Retention Intelligence' category in healthcare technology, Selected for the 2023 AWS Healthcare Accelerator

Growth metrics

Scaling through strategic co-development partnerships with major U.S. health systems; expanded product offering from core CRI to Patient Experience (PX) intelligence.

Market positioning

Specialized AI-driven workforce analytics provider for large-scale health systems and clinical leadership.

Geographic focus

North America

Patents and IP

Proprietary algorithms and data processing models; no specific public patent registrations disclosed as of latest update.

About Tiffany Chan

Tiffany Chan is the Co-Founder and CEO of Atalan. She has extensive experience in healthcare policy and workforce analytics, having previously served as a Research Center Manager at the Harvard John A. Paulson School of Engineering and Applied Sciences. Her background includes consultancy roles at The World Bank and Microsoft, as well as leadership involvement with the Coalition for Physician & APP Well-Being.

Official website: